Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Environmental Toxicology and Chemistry
|
July 26, 2011
Improving uncertainty analysis in kinetic evaluations using iteratively reweighted least squares
Zhenglei Gao, John W Green, Jan Vanderborght, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 30, 2008
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N Edginton, Frank-Peter Theil, Walter Schmitt, et al.
Journal of Medicinal Chemistry
|
July 23, 2004
A physiological model for the estimation of the fraction dose absorbed in humans
Stefan Willmann, Walter Schmitt, Jörg Keldenich, et al.
Environmental Toxicology and Chemistry
|
July 16, 2015
A toxicokinetic and toxicodynamic modeling approach using Myriophyllum spicatum to predict effects caused by short-term exposure to a sulfonylurea
Simon Heine, Frederik Schild, Walter Schmitt, et al.
Handbook of Experimental Pharmacology
|
November 19, 2015
Modeling and Simulation of In Vivo Drug Effects
Jörg Lippert, Rolf Burghaus, Lars Kuepfer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
April 14, 2007
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs
Stefan Willmann, Karsten Höhn, Andrea Edginton, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 3, 2018
Inhaled sGC Modulator Can Lower PH in Patients With COPD Without Deteriorating Oxygenation
Sina Saffaran, Wenfei Wang, Anup Das, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Integrated Environmental Assessment and Management
|
April 21, 2015
An example of population-level risk assessments for small mammals using individual-based population models
Walter Schmitt, Domenica Auteri, Finn Bastiansen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Environmental Toxicology and Chemistry
|
July 26, 2011
Improving uncertainty analysis in kinetic evaluations using iteratively reweighted least squares
Zhenglei Gao, John W Green, Jan Vanderborght, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 30, 2008
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N Edginton, Frank-Peter Theil, Walter Schmitt, et al.
Journal of Medicinal Chemistry
|
July 23, 2004
A physiological model for the estimation of the fraction dose absorbed in humans
Stefan Willmann, Walter Schmitt, Jörg Keldenich, et al.
Environmental Toxicology and Chemistry
|
July 16, 2015
A toxicokinetic and toxicodynamic modeling approach using Myriophyllum spicatum to predict effects caused by short-term exposure to a sulfonylurea
Simon Heine, Frederik Schild, Walter Schmitt, et al.
Handbook of Experimental Pharmacology
|
November 19, 2015
Modeling and Simulation of In Vivo Drug Effects
Jörg Lippert, Rolf Burghaus, Lars Kuepfer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
April 14, 2007
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs
Stefan Willmann, Karsten Höhn, Andrea Edginton, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 3, 2018
Inhaled sGC Modulator Can Lower PH in Patients With COPD Without Deteriorating Oxygenation
Sina Saffaran, Wenfei Wang, Anup Das, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Integrated Environmental Assessment and Management
|
April 21, 2015
An example of population-level risk assessments for small mammals using individual-based population models
Walter Schmitt, Domenica Auteri, Finn Bastiansen, et al.
Page
of 3